Valuation: Chrome Holding Co.

Market Cap 96.6M 85.83M 80.11M 73.01M 138M 9.29B 139M 969M 376M 4.75B 363M 355M 15.24B P/E 2024
-0.38x
P/E 2025 -0.07x
Enterprise Value 65.86M 58.52M 54.62M 49.78M 93.89M 6.33B 94.77M 661M 256M 3.24B 247M 242M 10.39B EV / Sales 2024
0.53x
EV / Sales 2025 -0.06x
Free-Float
68.5%
Yield 2024 *
-
Yield 2025 -
1 year 2.41
Extreme 2.41
3.93
3 years 0.47
Extreme 0.4701
20.4
5 years 0.47
Extreme 0.4701
273.6
10 years 0.47
Extreme 0.4701
363.2
Manager TitleAgeSince
Chief Executive Officer 63 2025-03-22
Chief Tech/Sci/R&D Officer - 2024-08-31
Chief Tech/Sci/R&D Officer 48 2006-12-31
Director TitleAgeSince
Chairman 52 2005-12-31
Director/Board Member 57 2024-10-27
Director/Board Member 61 2024-10-27
Date Insider Type Main position Quantity % Market Cap. Importance
8/20/25 Tax

Chief Executive Officer

5,232 0.0206%
6/9/25 Conversion

Founder

4,931,692 25.0063%
5/20/25 Tax

Chief Executive Officer

5,073 0.0257%
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%-.--%-9.68%-81.68% 96.4M
+1.48%-3.00%+11.63%+24.06% 111B
+0.78%-2.05%0.00%+72.60% 92.38B
+0.46%-0.54%+156.13%+839.45% 59.15B
-0.38%-5.45%-7.18%+53.64% 27.66B
+0.97%-1.27%+28.94%+92.98% 25.75B
+1.28%-0.37%+10.40%+54.59% 25.02B
-0.57%+0.09%-15.78%-7.70% 20.99B
+1.83%-0.42%+27.16%+290.84% 20.82B
+1.30%-2.86%-5.57%+34.95% 16.87B
Average +0.44%-0.88%+19.61%+137.37% 39.93B
Weighted average by Cap. +0.89%-2.05%+28.72%+177.15%

Financials

2024 2025
Net sales 220M 195M 182M 166M 313M 21.11B 316M 2.2B 854M 10.79B 825M 807M 34.64B 190M 169M 157M 144M 271M 18.26B 273M 1.91B 738M 9.33B 713M 697M 29.95B
Net income -667M -592M -553M -504M -950M -64.09B -959M -6.69B -2.59B -32.76B -2.5B -2.45B -105B -281M -250M -233M -212M -400M -27B -404M -2.82B -1.09B -13.8B -1.05B -1.03B -44.3B
Net Debt -140M -124M -116M -106M -200M -13.46B -201M -1.4B -544M -6.88B -526M -514M -22.08B -30.74M -27.31M -25.49M -23.23M -43.81M -2.95B -44.22M -308M -120M -1.51B -115M -113M -4.85B
Logo Chrome Holding Co.
Chrome Holding Co., formerly 23andMe Holding Co., is a genetics-led consumer healthcare company. As a part of TTAM Research Institute (TTAM), the Company operates and provides customers with personalized deoxyribonucleic acid (DNA) testing and research services.
Employees
261
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB